Mergers & Acquisitions - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

201 to 225 of 256 results

Empty pipelines drive deal valuations in pharmaceuticals sector, say IMAP

10-05-2012

A drought of domestic growth opportunities and new products is inflating valuations for R&D companies…

BiotechnologyMergers & AcquisitionsPharmaceuticalResearch

S&N launches new biologics firm, Bioventus, with focus on active orthopaedic healing

08-05-2012

Bioventus, a new company providing active orthopaedic healing, launched yesterday following the finalization…

Anti-Arthritics/RheumaticsBiotechnologyBioventusMarkets & MarketingMergers & AcquisitionsSmith & Nephew

Life sciences M&A activity heats Up in April, says Burrill & Co

07-05-2012

April proved to be a big month for M&A activity in the life sciences as companies announced more than…

BiotechnologyFinancialMergers & AcquisitionsPharmaceutical

Amylin operating loss leaps to over $30 million

27-04-2012

US biotech firm Amylin Pharmaceuticals (Nasdaq AMLN): reported financial results for the quarter ended…

AmylinBiotechnologyFinancialMergers & Acquisitions

Amgen acquires Turkish drugmaker Mustafa Nevzat for $700 million

26-04-2012

Global biotech giant Amgen (Nasdaq: AMGN) has reached agreement to acquire 95.6% of Mustafa Nevzat Pharmaceuticals…

AmgenBiotechnologyMergers & AcquisitionsMustafa Nevzat PharmaPharmaceutical

Biota and Nabi announce proposed merger

24-04-2012

Australian firm Biota Holdings (ASX: BTA) and USA-based Nabi Biopharmaceuticals (Nasdaq: NABI) yesterday…

Biota HoldingsBiota PharmaceuticalsBiotechnologyMergers & AcquisitionsNabi BiopharmaceuticalsPharmaceutical

AstraZeneca to acquire Ardea Bio for $1.26 billion

23-04-2012

In line with its stated policy of making strategic, rather than mega, acquisitions, Anglo-Swedish drug…

Anti-Arthritics/RheumaticsArdea BiosciencesAstraZenecaBiotechnologyGenito-urinarylesinuradMergers & AcquisitionsPharmaceutical

Human Genome rejects unsolicited takeover bid from GlaxoSmithKline

20-04-2012

US drugmaker Human Genome Sciences (Nasdaq: HGSI) revealed yesterday that it has rejected an unsolicited…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Roche will not extend its tender offer for Illumina

19-04-2012

In view of the apparent re-election of the incumbent directors of Illumina (Nasdaq: ILMN), a leading…

BiotechnologyIlluminaMergers & AcquisitionsPharmaceuticalRoche

Arrowhead takes over Alvos Thera in stock deal

12-04-2012

USA-based nano-medicine developer Arrowhead Research Corp (Nasdaq: ARWR) says it has acquired Alvos Therapeutics…

Alvos TherapeuticsArrowhead ResearchBiotechnologyMergers & AcquisitionsPharmaceutical

Amgen to snap up KAI Pharma for $315 million

11-04-2012

In a second acquisition announced so far this year, global biotech leader Amgen (Nasdaq: AMGN) said yesterday…

AmgenBiotechnologyKAI PharmaceuticalsMergers & AcquisitionsNephrology and Hepatology

Spectrum plunges on negative trial results; makes bid for Allos

10-04-2012

US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) saw its shares plunge as much as 14%, before…

Allos TherapeuticsapaziquoneBiotechnologyFolotynMergers & AcquisitionsOncologyPharmaceuticalResearchSpectrum Pharmaceuticals

Investor Icahn slams Amylin for not revealing B-MS bid

05-04-2012

Billionaire US investor Carl Icahn has sent a blistering open letter to the board of US biotech company…

AmylinBiotechnologyBristol-Myers SquibbMergers & AcquisitionsPharmaceutical

Government, academic and venture firms come together in March to fund translational and early-stage development

02-04-2012

A host of new initiatives focused on funding translational research and early-stage companies brought…

BiotechnologyFinancialMergers & AcquisitionsPharmaceutical

Kyowa Hakko sets up biosimilars joint venture with Fujifilm

29-03-2012

Japanese digital camera and medical equipment conglomerate Fujifilm and drugmaker Kyowa Hakko Kirin have…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyFujifilm Kyowa Kirin BiologicsGenericsHumiraKyowa Hakko KirinMergers & AcquisitionsResearch

Roche ups bid for Illumina; M&A speculation on Amylin, Actavis

29-03-2012

There was a plethora of merger and acquisition news coming out yesterday and this morning, first of which…

ActavisAmylinBiotechnologyBristol-Myers SquibbGenericsIlluminaMergers & AcquisitionsMylan LaboratoriesPharmaceuticalRocheWatson Pharmaceuticals

Islet Sciences closes stock acquisition of diabetes drug developer DiaKine

26-03-2012

New York. USA-based biotech company Islet Sciences (OTC.BB: ISLT),said Friday that it has closed its…

BiotechnologyDiabetesDiaKine TherapeuticsIslet SciencesMergers & Acquisitions

Anaphore buys Chinese firm RuiYi for GPCR biologics platform

23-03-2012

Privately-held US company Anaphore says it has acquired Shanghai, China-based RuiYi, bringing the company…

AnaphoreAsia-PacificBiotechnologyMergers & AcquisitionsRuiYi

NicOx takes option to buy UK ophthalmic company

22-03-2012

French biotechnology firm NicOx (Euronext Paris: COX) has entered into an agreement to acquire 11.8%…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmicsPharmaceutical

Grifols acquires 51% stake in Araclon Biotech

19-03-2012

Spanish plasma products specialist Grifols (MCE: GRF) has acquired 51% of the equity of Zaragoza, Spain-based…

Araclon BiotechBiotechnologyGrifolsMergers & AcquisitionsNeurologicalPharmaceuticalVaccines

Valeant on acquisition trail again

12-03-2012

In a third acquisition deal announced so far this year, Canada-based Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsPele Nova BiotecnologiaPharmaceuticalRegedermSouth AmericaValeant Pharmaceuticals

Amgen says tender offer for Micromet on track

04-03-2012

Global biotech leader Amgen (Nasdaq: AMGN) says that all conditions to the closing of the tender offer…

AmgenBiotechnologyMergers & AcquisitionsMicromet

201 to 225 of 256 results

Back to top